Characteristics of women not receiving treatment with 17-alpha-hydroxyprogesterone-caproate for a history of spontaneous preterm birth

被引：0
|
作者：
Massa, Katherine [1 ]
Lawlor, Megan L. [2 ]
Boerrigter, Ashley [1 ]
Vricella, Laura K. [2 ]
Childress, Katherine S. [3 ]
机构：
[1] St Louis Univ, St Louis, MO 63103 USA
[2] St Louis Univ, Sch Med, Div Maternal Fetal Med, St Louis, MO USA
[3] St Louis Univ, Sch Med, St Louis, MO USA
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2020年 / 222卷 / 01期
关键词：
D O I：
10.1016/j.ajog.2019.11.940
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
929
引用
收藏
页码：S574 / S575
页数：2
相关论文
共 50 条
  • [1] Spontaneous Preterm Birth in African-American and Caucasian Women Receiving 17α-Hydroxyprogesterone Caproate
    Timofeev, Julia
    Singh, Jasbir
    Istwan, Niki
    Rhea, Debbie
    Driggers, Rita W.
    AMERICAN JOURNAL OF PERINATOLOGY, 2014, 31 (01) : 55 - 60
  • [2] Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
    Baha Sibai
    George R. Saade
    Anita F. Das
    Jennifer Gudeman
    Journal of Perinatology, 2021, 41 : 718 - 725
  • [3] Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
    Sibai, Baha
    Saade, George R.
    Das, Anita F.
    Gudeman, Jennifer
    JOURNAL OF PERINATOLOGY, 2021, 41 (04) : 718 - 725
  • [4] The Risk for Preterm Labor in Women Receiving 17 Alpha-Hydroxyprogesterone Caproate Prophylaxis for Preterm Birth Prevention
    Joy, Saju
    Rhea, Debbie J.
    Istwan, Niki B.
    Desch, Cheryl N.
    Stanziano, Gary
    AMERICAN JOURNAL OF PERINATOLOGY, 2010, 27 (04) : 343 - 348
  • [5] Uterine activity in women receiving 17α-hydroxyprogesterone caproate for preterm birth prevention
    Allen, Shannon J.
    O'Brien, John M.
    Stanziano, Gary J.
    Barton, John R.
    OBSTETRICS AND GYNECOLOGY, 2008, 111 (04): : 101S - 101S
  • [6] 17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth
    Merlob, Paul
    Stahl, Bracha
    Klinger, Gil
    REPRODUCTIVE TOXICOLOGY, 2012, 33 (01) : 15 - 19
  • [7] Risk factors for spontaneous preterm birth in African-American and Caucasian women receiving 17α-hydroxyprogesterone caproate
    Timofeev, Julia
    Singh, Jasbir
    Istwan, Niki
    Rhea, Debbie
    Driggers, Rita
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (01) : S258 - S259
  • [8] Relationship between 17-alpha hydroxyprogesterone caproate concentration and spontaneous preterm birth
    Caritis, Steve N.
    Venkataramanan, Raman
    Thom, Elizabeth
    Harper, Margaret
    Klebanoff, Mark A.
    Sorokin, Yoram
    Thorp, John M., Jr.
    Varner, Michael W.
    Wapner, Ronald J.
    Iams, Jay D.
    Carpenter, Marshall W.
    Grobman, William A.
    Mercer, Brian M.
    Sciscione, Anthony
    Rouse, Dwight J.
    Ramin, Susan
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 210 (02) : 128.e1 - 128.e6
  • [9] 17 alpha-hydroxyprogesterone caproate, HIV, and preterm birth
    Ntozini, Robert
    Prendergast, Andrew J.
    LANCET HIV, 2021, 8 (10): : E600 - E601
  • [10] Is the risk of gestational diabetes increased in women treated with 17-alpha-hydroxyprogesterone-caproate?
    Massa, Katherine
    Mostello, Dorothea
    Childress, Katherine S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S417 - S418
12345